Experience with combined vaccines in children


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Postvaccination histories were investigated in patients aged 3 to 8 years who had received a pentavalent vaccine containing an acellular pertussis component or a trivalent vaccine against measles, parotiditis, and rubella. The findings suggest that there are low rates of systemic and local reactions to immunization when these vaccines are used. The paper also shows the results of a questionnaire survey in the children’s parents, which reflect their opinion on some aspects of vaccination.

Full Text

Restricted Access

About the authors

Kh. Kh Shakova

Kh.M. Berbekov Kabardino-Balkar State University; Center for Prevention and Control of AIDS and Infectious Diseases, Ministry of Health of the Kabardino-Balkar Republic

Email: hidaz@mail.ru
Nalchik

M. R Ivanova

Kh.M. Berbekov Kabardino-Balkar State University; Center for Prevention and Control of AIDS and Infectious Diseases, Ministry of Health of the Kabardino-Balkar Republic

Email: marina19692003@list.ru
Nalchik

A. Kh Shakova

Kh.M. Berbekov Kabardino-Balkar State University

Email: hidaz@mail.ru
Nalchik

References

  1. Таточенко В.К., Озерецковский Н.А., Федоров А.М. Иммунопрофилактика-2014. Справочник. М.: Педиатрь, 2014. 278 с.
  2. Широкова В.И. Принципиальные подходы к вакцинопрофилактике у детей. Лекции по педиатрии. Т. 9. Иммунология. М.: РГМУ, 2010; 310-318.
  3. Костинов М.П., Тарасова А.А. Вакцинопрофилактика пневмококковой инфекции и гриппа при аутоиммунных заболеваниях. М.: МДВ, 2009; 11-15.
  4. Diseases and the Vaccines that Prevent Them. http://www.cdc.gov/ vaccines /hcp/conversations/prevent-diseases/provider-resources-factsheets-infants.html
  5. Костинов М.П., Лавров В.Ф. Вакцины нового поколения в профилактике инфекционных заболеваний. М.: МДВ, 2010. 192 с.
  6. Шпеер Е.Л., Дьяков И.Н. Комбинированные вакцины. В кн.: Зверев В.В, Хаитов Р.М. (ред.). Вакцины и вакцинация. М.: «ГЭОТАР-Медиа», 2014; 510-521.
  7. Малеев В.В., Таточенко В.К., Зайцев Е.М. Вакцины для профилактики дифтерии, столбняка, коклюша. В кн.: Зверев B.В, Хаитов Р.М. (ред.). Вакцины и вакцинация. М.: ГЭОТАР-Медиа, 2014; 314-326.
  8. Баранов А.А., Хаитов Р.М. (ред.). Аллергология и иммунология. М.: ООО «Депо», 2011; 214-240.
  9. Шигина Ю.В. Клиническая иммунология. М.: РИОР, 2006. 302 с.
  10. Pertussis: Summary of Vaccine Recommendations For Health Care Professionals. http://www.cdc.gov/vaccines/vpd-vac/ pertussis/recs-summary.htm
  11. The Australian Immunisation Handbook 10th Edition (updated June 2015): 4.12 Pertussis. http://www.immunise. health.gov.au/internet/immunise/publishing.nsf/Content/ Handbook10-home~handbook10part4~handbook10-4-12.
  12. Juretzko P., von Kries R., Hermann M., Wirsing von König C. H., Weil J., Giani G. Effectiveness of Acellular Pertussis Vaccine Assessed by Hospital-Based Active Surveillance in Germany. Clin. Infect. Dis. 2002; 35(2): 162-167.
  13. Baxter R., Bartlett J., Rowhani-Rahbar A., Fireman B., Klein N.P. Effectiveness of pertussis vaccines for adolescents and adults: case-control study. BMJ 2013; 347: f 4249.
  14. Amirthalingam G., Andrews N., Campbell H., Ribeiro S., Kara E., Donegan K., Fry N.K., E. Miller, M. Ramsay Effectiveness of maternal pertussis vaccination in England: an observational study. Lancet 2014; 384(9953): 1521-1528.
  15. Dabrera G., Amirthalingam G., Andrews N., Campbell H., Ribeiro S., Kara E., Fry N.K., Ramsay M. A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales, 2012-2013. Clin. Infect. Dis. 2015; 60(3): 333-337.
  16. Forsyth K., Plotkin S., Tan T., Wirsing von König C.H. Strategies to Decrease Pertussis Transmission to Infants. Pediatrics 2015; 135(6): e1475- e1482.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies